Ryan Specialty (NYSE:RYAN – Get Free Report) is anticipated to post its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect Ryan Specialty to post earnings of $0.4854 per share and revenue of $792.99 million for the quarter. Investors may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, October 29, 2026 at 4:45 PM ET.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.14. The business had revenue of $916.65 million during the quarter, compared to the consensus estimate of $873.93 million. Ryan Specialty had a return on equity of 43.97% and a net margin of 7.55%. Ryan Specialty’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.66 EPS. On average, analysts expect Ryan Specialty to post $2.17 EPS for the current fiscal year and $2.47 EPS for the next fiscal year.
Ryan Specialty Stock Performance
NYSE:RYAN opened at $44.56 on Tuesday. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 3.51. The stock’s 50-day simple moving average is $40.35 and its 200 day simple moving average is $39.32. The firm has a market capitalization of $11.40 billion, a PE ratio of 61.89, a price-to-earnings-growth ratio of 0.90 and a beta of 0.61.
Ryan Specialty Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 25th. Shareholders of record on Tuesday, August 11th were paid a dividend of $0.13 per share. The ex-dividend date of this dividend was Tuesday, August 11th. This represents a $0.52 annualized dividend and a yield of 1.2%. Ryan Specialty’s payout ratio is presently 72.22%.
Analysts Set New Price Targets
A number of research firms have recently commented on RYAN. Zacks Research raised shares of Ryan Specialty from a “strong sell” rating to a “hold” rating in a report on Tuesday, June 30th. Royal Bank Of Canada lifted their price target on shares of Ryan Specialty from $45.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Keefe, Bruyette & Woods upped their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. UBS Group increased their price objective on shares of Ryan Specialty from $50.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Finally, Wells Fargo & Company dropped their price objective on shares of Ryan Specialty from $43.00 to $41.00 and set an “equal weight” rating for the company in a research note on Monday, October 12th. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Ryan Specialty has an average rating of “Hold” and an average target price of $52.21.
View Our Latest Research Report on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.
Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.
See Also
- Five stocks we like better than Ryan Specialty
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
